Azithromycin STADA Filmuhúðuð tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

azithromycin stada filmuhúðuð tafla 500 mg

stada arzneimittel ag - azithromycinum mónóhýdrat - filmuhúðuð tafla - 500 mg

Azithromycin STADA Mixtúruduft, dreifa 40 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

azithromycin stada mixtúruduft, dreifa 40 mg/ml

stada arzneimittel ag - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml

Azyter Augndropar, lausn í stakskammtaíláti 15 mg/g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

azyter augndropar, lausn í stakskammtaíláti 15 mg/g

laboratoires thea s.a.s. - azithromycinum díhýdrat - augndropar, lausn í stakskammtaíláti - 15 mg/g

Vigamox (Moxifloxacin Alcon) Augndropar, lausn 5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vigamox (moxifloxacin alcon) augndropar, lausn 5 mg/ml

novartis healthcare a/s - moxifloxacinum hýdróklóríð - augndropar, lausn - 5 mg/ml

Doxycyklin EQL Pharma Tafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

doxycyklin eql pharma tafla 100 mg

eql pharma ab - doxycyclinum inn - tafla - 100 mg

Doxylin Tafla 100 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

doxylin tafla 100 mg

actavis group ptc ehf. - doxycyclinum inn - tafla - 100 mg

Zitromax Filmuhúðuð tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zitromax filmuhúðuð tafla 500 mg

pfizer aps - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg

Coxevac Evrópusambandið - íslenska - EMA (European Medicines Agency)

coxevac

ceva santé animale - óvirkt coxiella burnetii bóluefni, stofn nine mile - immunologicals for bovidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - goats; cattle - cattle: , for the active immunisation of cattle to lower the risk for non-infected animals vaccinated when non-pregnant to become shedder (5 times lower probability in comparison with animals receiving a placebo), and to reduce shedding of coxiella burnetii in these animals via milk and vaginal mucus. , onset of immunity: not established. , duration of immunity: 280 days after completion of the primary vaccination course. , goats: , for the active immunisation of goats to reduce abortion caused by coxiella burnetii and to reduce shedding of the organism via milk, vaginal mucus, faeces and placenta. , onset of immunity: not established. , duration of immunity: one year after completion of the primary vaccination course.

Ecoporc Shiga Evrópusambandið - íslenska - EMA (European Medicines Agency)

ecoporc shiga

ceva santé animale - erfðabreytt skal læknir hafa upplýsingar-eitur-2e antigen - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - svín - virkur ónæmisaðgerð grísla frá fjórum dögum, til að draga úr dauðsföllum og klínískum einkennum bjúgsjúkdóms af völdum shiga toxíns 2e framleitt með escherichia coli (stec). upphaf ónæmis: 21 dagar eftir bólusetningu. lengd ónæmis: 105 dögum eftir bólusetningu.

Eryseng Evrópusambandið - íslenska - EMA (European Medicines Agency)

eryseng

laboratorios hipra, s.a. - erysipelothrix rhusiopathiae, stofn r32e11 (óvirkt) - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - svín - fyrir virka bólusetningar af karlkyns og kvenkyns svín til að draga úr klínískum merki (húð og hiti) af svín erysipelas af völdum erysipelothrix rhusiopathiae, serotype 1 og 2 serotype.